These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3781329)

  • 1. Faecal metronidazole concentrations during oral and intravenous therapy for antibiotic associated colitis due to Clostridium difficile.
    Bolton RP; Culshaw MA
    Gut; 1986 Oct; 27(10):1169-72. PubMed ID: 3781329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea.
    Wenisch C; Parschalk B; Hasenhündl M; Hirschl AM; Graninger W
    Clin Infect Dis; 1996 May; 22(5):813-8. PubMed ID: 8722937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is shorter also better in the treatment of Clostridioides difficile infection?
    Duricek M; Halmova K; Krutova M; Sykorova B; Benes J
    J Antimicrob Chemother; 2024 Jun; 79(6):1413-1417. PubMed ID: 38661207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving
    Adukauskienė D; Mickus R; Dambrauskienė A; Vanagas T; Adukauskaitė A
    Antibiotics (Basel); 2024 Jan; 13(1):. PubMed ID: 38247610
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibiotic Resistances of Clostridioides difficile.
    Spigaglia P; Mastrantonio P; Barbanti F
    Adv Exp Med Biol; 2024; 1435():169-198. PubMed ID: 38175476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial Efficacy Evaluations of Metronidazole against Clostridioides difficile Infection using Fecal Pharmacokinetic and Pharmacodynamic Analyses.
    Tashiro S; Taguchi K; Enoki Y; Matsumoto K
    Pharm Res; 2023 Jul; 40(7):1799-1806. PubMed ID: 37226025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota interspecies interactions shape the response of Clostridioides difficile to clinically relevant antibiotics.
    Hromada S; Venturelli OS
    PLoS Biol; 2023 May; 21(5):e3002100. PubMed ID: 37167201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal therapeutic recommendation for Clostridioides difficile infection in pediatric and adolescent populations: a systematic review and meta-analysis.
    Tashiro S; Mihara T; Okawa R; Tanaka Y; Samura M; Enoki Y; Taguchi K; Matsumoto K; Yamagishi Y
    Eur J Pediatr; 2023 Jun; 182(6):2673-2681. PubMed ID: 37000258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance of Clostridioides difficile Antimicrobial Resistance in the United States.
    Gonzales-Luna AJ; Dureja C; Eubank TA; Garey KW; Hurdle JG
    Clin Infect Dis; 2023 Jun; 76(11):2038-2039. PubMed ID: 36883582
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of Clostridioides difficile infection in adults and challenges in clinical practice: review and comparison of current IDSA/SHEA, ESCMID and ASID guidelines.
    Bishop EJ; Tiruvoipati R
    J Antimicrob Chemother; 2022 Dec; 78(1):21-30. PubMed ID: 36441203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors, Diagnosis, and Management of
    Del Vecchio LE; Fiorani M; Tohumcu E; Bibbò S; Porcari S; Mele MC; Pizzoferrato M; Gasbarrini A; Cammarota G; Ianiro G
    Microorganisms; 2022 Jun; 10(7):. PubMed ID: 35889034
    [No Abstract]   [Full Text] [Related]  

  • 12. Which is the Preferred Regimen for Non-Severe
    Kim J; Kim J; Kim B; Pai H
    Infect Chemother; 2022 Jun; 54(2):213-219. PubMed ID: 35706079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Subinhibitory Concentrations of Metronidazole on Morphology, Motility, Biofilm Formation and Colonization of
    Doan TH; Bernet-Camard MF; Hoÿs S; Janoir C; Péchiné S
    Antibiotics (Basel); 2022 May; 11(5):. PubMed ID: 35625268
    [No Abstract]   [Full Text] [Related]  

  • 14. Emergence of Clinical Clostridioides difficile Isolates With Decreased Susceptibility to Vancomycin.
    Darkoh C; Keita K; Odo C; Oyaro M; Brown EL; Arias CA; Hanson BM; DuPont HL
    Clin Infect Dis; 2022 Jan; 74(1):120-126. PubMed ID: 35016207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced Susceptibility to Metronidazole Is Associated With Initial Clinical Failure in
    Gonzales-Luna AJ; Olaitan AO; Shen WJ; Deshpande A; Carlson TJ; Dotson KM; Lancaster C; Begum K; Alam MJ; Hurdle JG; Garey KW
    Open Forum Infect Dis; 2021 Aug; 8(8):ofab365. PubMed ID: 34381844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Integrity of Heme Is Essential for Reproducible Detection of Metronidazole-Resistant Clostridioides difficile by Agar Dilution Susceptibility Tests.
    Wu X; Shen WJ; Deshpande A; Olaitan AO; Palmer KL; Garey KW; Hurdle JG
    J Clin Microbiol; 2021 Aug; 59(9):e0058521. PubMed ID: 34132582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of clinical guidelines for antimicrobial management of
    Chaar A; Feuerstadt P
    Therap Adv Gastroenterol; 2021; 14():17562848211011953. PubMed ID: 33995583
    [No Abstract]   [Full Text] [Related]  

  • 18. Haem is crucial for medium-dependent metronidazole resistance in clinical isolates of Clostridioides difficile.
    Boekhoud IM; Sidorov I; Nooij S; Harmanus C; Bos-Sanders IMJG; Viprey V; Spittal W; Clark E; Davies K; Freeman J; Kuijper EJ; Smits WK;
    J Antimicrob Chemother; 2021 Jun; 76(7):1731-1740. PubMed ID: 33876817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of subinhibitory concentrations of metronidazole on proteome of Clostridioides difficile strains with different levels of susceptibility.
    Doan TH; Yen-Nicolaÿ S; Bernet-Camard MF; Martin-Verstraete I; Péchiné S
    PLoS One; 2020; 15(11):e0241903. PubMed ID: 33166349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrapotent Inhibitor of
    Naclerio GA; Abutaleb NS; Li D; Seleem MN; Sintim HO
    J Med Chem; 2020 Oct; 63(20):11934-11944. PubMed ID: 32960605
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.